Diagnosis (Berlin, Germany) · 2026
Evaluation of a new non-competitive chemiluminescent immunoassay for 25-OH vitamin D measurement.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhong Jinqing, Huang Binning, Lin Aihua, Wu Geng, Zhang Lili, Yu Xiaowei, Zhuang Shun, Zheng Daying, Chen Huangxing, Zhang Zhongying
Аннотация
OBJECTIVES: The increasing demand for vitamin D measurement over the past few decades has prompted manufacturers to develop automated chemiluminescence immunoassay (CLIA), including the noncompetitive anti-immune complex assay (NACA) system for the measurement of small molecules. This study aims to evaluate the performance of the Snibe-NACA 25-OH Vitamin D assay for measuring total 25-Hydroxy Vitamin D assay [25(OH)D] levels.
METHODS: A total of 200 serum samples were collected from a clinical laboratory for 25(OH)D assay to evaluate the performance of the Snibe-NACA 25-OH Vitamin D assay using a double-blind method. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used as a reference method and the results were compared with those obtained from four other chemiluminescence competitive 25(OH)D assays.
RESULTS: The Snibe-NACA 25-OH Vitamin D assay demonstrated satisfactory analytical performance with optimal precision (repeatability CV: 1.13-2.75 %;intra-laboratory CV: 1.59-2.58 %) and relatively small bias (-3.84 % mean relative bias compared with the LC-MS/MS),excellent agreement with LC-MS/MS, as evidenced by Passing-Bablok regression (R2: 0.9245, slope: 0.99, 95 % CI: 0.96-1.03; intercept: -1.24, 95 % CI: -3.49 to 0.65) and high correlation (Spearman's ρ=0.969; ICC=0.9584). Notably, the assay showed the highest concordance with LC-MS/MS in the classification of vitamin D status, achieving an overall agreement of 87.0 %, with particularly strong concordance in identifying deficiency (97.8 %).
CONCLUSIONS: The Snibe-NACA 25-OH Vitamin D assay demonstrated good performance and compared favorably with both LC-MS/MS and other competitive assays, providing evidence of its high reliability in clinical diagnostic practice.
METHODS: A total of 200 serum samples were collected from a clinical laboratory for 25(OH)D assay to evaluate the performance of the Snibe-NACA 25-OH Vitamin D assay using a double-blind method. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used as a reference method and the results were compared with those obtained from four other chemiluminescence competitive 25(OH)D assays.
RESULTS: The Snibe-NACA 25-OH Vitamin D assay demonstrated satisfactory analytical performance with optimal precision (repeatability CV: 1.13-2.75 %;intra-laboratory CV: 1.59-2.58 %) and relatively small bias (-3.84 % mean relative bias compared with the LC-MS/MS),excellent agreement with LC-MS/MS, as evidenced by Passing-Bablok regression (R2: 0.9245, slope: 0.99, 95 % CI: 0.96-1.03; intercept: -1.24, 95 % CI: -3.49 to 0.65) and high correlation (Spearman's ρ=0.969; ICC=0.9584). Notably, the assay showed the highest concordance with LC-MS/MS in the classification of vitamin D status, achieving an overall agreement of 87.0 %, with particularly strong concordance in identifying deficiency (97.8 %).
CONCLUSIONS: The Snibe-NACA 25-OH Vitamin D assay demonstrated good performance and compared favorably with both LC-MS/MS and other competitive assays, providing evidence of its high reliability in clinical diagnostic practice.